Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Endometrial Neoplasms and FGFR2[original query] |
|---|
| Novel breast cancer risk alleles and endometrial cancer risk. International journal of cancer. Journal international du cancer 2008 Dec 123 (12): 2961-4. McGrath Monica, Lee I-Min, Buring Julie, Hunter David J, De Vivo Immacula |
| FGFR2 mutations are rare across histologic subtypes of ovarian cancer. Gynecologic oncology 2010 Apr 117 (1): 125-9. Byron Sara A, Gartside Michael G, Wellens Candice L, Goodfellow Paul J, Birrer Michael J, Campbell Ian G, Pollock Pamela |
| FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features. PloS one 2012 7 (2): e30801. Byron Sara A, Gartside Michael, Powell Matthew A, Wellens Candice L, Gao Feng, Mutch David G, Goodfellow Paul J, Pollock Pamela |
| Rapid Identification of FGFR2 Gene Mutations in Taiwanese Patients With Endometrial Cancer Using High-resolution Melting Analysis. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2015 Aug 23 (7): 532-7. Lin Yi-Ching, Er Tze-Kiong, Yeh Kun-Tu, Hung Chih-Hsing, Chang Jan-Gow |
| Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study. The Lancet. Oncology 2015 Jun 16 (6): 686-94. Konecny Gottfried E, Finkler Neil, Garcia Agustin A, Lorusso Domenica, Lee Paula S, Rocconi Rodney P, Fong Peter C, Squires Matt, Mishra Kaushal, Upalawanna Allison, Wang Yongyu, Kristeleit Rebec |
| Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jun 28 (6): 836-44. Stelloo Ellen, Bosse Tjalling, Nout Remi A, MacKay Helen J, Church David N, Nijman Hans W, Leary Alexandra, Edmondson Richard J, Powell Melanie E, Crosbie Emma J, Kitchener Henry C, Mileshkin Linda, Pollock Pamela M, Smit Vincent T, Creutzberg Carien |
| Genetic alterations in endometrial cancer by targeted next-generation sequencing. Experimental and molecular pathology 2015 Nov . Chang Ya-Sian, Huang Hsien-Da, Yeh Kun-Tu, Chang Jan-Gow |
| FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic oncology 2017 Mar . Jeske Yvette W, Ali Shamshad, Byron Sara A, Gao Feng, Mannel Robert S, Ghebre Rahel G, DiSilvestro Paul A, Lele Shashikant B, Pearl Michael L, Schmidt Amy P, Lankes Heather A, Ramirez Nilsa C, Rasty Golnar, Powell Matthew, Goodfellow Paul J, Pollock Pamela |
| Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study. Gynecologic oncology 2021 7 162 (3): 694-701. Victoor Jasper, Borght Sara Vander, Spans Lien, Lehnert Stefan, Brems Hilde, Laenen Annouschka, Vergote Ignace, Van Gorp Toon, Van Nieuwenhuysen Els, Han Sileny, Timmerman Stefan, Van Rompuy Anne-Sophie, Vanden Bempt Isabel |
| Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial Cancer. JCO precision oncology 2022 Feb 6 e2100401. Choi Jungyoon, Holowatyj Andreana N, Du Mengmeng, Chen Zhishan, Wen Wanqing, Schultz Nikolaus, Lipworth Loren, Guo Xing |
| The Roles of TP53 and FGFR2 in Progress Made Treating Endometrial Cancer. Diagnostics (Basel, Switzerland) 2022 Jul 12 (7): . Adamczyk-Gruszka Olga, Horecka-Lewitowicz Agata, Strzelecka Agnieszka, Wawszczak-Kasza Monika, Gruszka Jakub, Lewitowicz Pio |
| Functional Distinctions of Endometrial Cancer-Associated Mutations in the Fibroblast Growth Factor Receptor 2 Gene. Cells 2023 9 12 (18): . Garima Dixit, Benjamin A Pappas, Gourav Bhardwaj, Willow Schanz, Thorsten Maretz |
- Page last reviewed:Feb 1, 2024
- Content source: